Elizabeth Holmes told a San Jose federal jury Monday that research with pharmaceutical giants and Stanford University indicated that the technology used by her defunct blood-testing company Theranos was “very reputable.”

The former Silicon Valley CEO’s testimony sought to contradict the government’s criminal fraud case accusing Holmes of defrauding investors, doctors and patients with faulty technology. Holmes’ Williams & Connolly counsel, who unexpectedly put her on the stand Nov. 19 in U.S. District Judge Edward Davila’s Northern District of California courtroom, sought to characterize her understanding of the technology’s functionality between 2008 and 2015.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]